Efficacy of oral treprostinil for treating pulmonary arterial hypertension: a systematic review and meta-analysis

Gelijkaardige items

• The Importance of Dose Escalation in the Treatment of Pulmonary Arterial Hypertension with Treprostinil
  door: Piotr Kędzierski, et al.
  Gepubliceerd in: (2025-01-01)
• Evaluation of patients with severe pulmonary hypertension and a range of comorbidities prescribed inhaled treprostinil
  door: Aparna C. Swaminathan, et al.
  Gepubliceerd in: (2024-11-01)
• Survival and drug persistence in patients receiving inhaled treprostinil at doses greater than 54 µg (nine breaths) four times daily
  door: Shelley Shapiro, et al.
  Gepubliceerd in: (2021-10-01)
• Peak steps to measure ‘‘capacity for activity’’: Actigraphy in the ADAPT registry with oral treprostinil
  door: Daniel Lachant, DO, et al.
  Gepubliceerd in: (2025-05-01)
• Implementing the EXPEDITE parenteral induction protocol: Rapid parenteral treprostinil titration and transition to oral treprostinil
  door: John F. Kingrey, et al.
  Gepubliceerd in: (2023-07-01)